Literature DB >> 2954006

[Megestrol acetate versus medroxyprogesterone acetate in the treatment of metastasizing breast cancers. Intermediate report of a multicenter phase III study].

H E Wander, U R Kleeberg, E Gärtner, J Hartlapp, A Scherpe, E Bönisch, G A Nagel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2954006     DOI： 10.1159/000216383

Source DB:  PubMed          Journal:  Onkologie        ISSN： 0378-584X


× No keyword cloud information.
  3 in total

Review 1.  Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.

Authors:  P E Lønning; E A Lien; S Lundgren; S Kvinnsland
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

2.  Influence of aminoglutethimide on the metabolism of medroxyprogesterone acetate and megestrol acetate in postmenopausal patients with advanced breast cancer.

Authors:  S Lundgren; P E Lønning; A Aakvaag; S Kvinnsland
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  Megestrol acetate versus aminoglutethimide for metastatic breast cancer.

Authors:  S Lundgren; S Gundersen; R Klepp; P E Lønning; E Lund; S Kvinnsland
Journal:  Breast Cancer Res Treat       Date:  1989-11       Impact factor: 4.872
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.